Global Meningococcal Group B Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Meningococcal Group B Vaccine market size was valued at USD 1139 million in 2023 and is forecast to a readjusted size of USD 1981.4 million by 2030 with a CAGR of 8.2% during review period.
Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Meningococcal Group B Vaccine industry chain, the market status of Public (Bexsero, Trumenba), Private (Bexsero, Trumenba), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Meningococcal Group B Vaccine.
Regionally, the report analyzes the Meningococcal Group B Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Meningococcal Group B Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Meningococcal Group B Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Meningococcal Group B Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Bexsero, Trumenba).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Meningococcal Group B Vaccine market.
Regional Analysis: The report involves examining the Meningococcal Group B Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Meningococcal Group B Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Meningococcal Group B Vaccine:
Company Analysis: Report covers individual Meningococcal Group B Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Meningococcal Group B Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Meningococcal Group B Vaccine. It assesses the current state, advancements, and potential future developments in Meningococcal Group B Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Meningococcal Group B Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Meningococcal Group B Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Meningococcal Group B Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Group B Vaccine, with price, sales, revenue and global market share of Meningococcal Group B Vaccine from 2019 to 2024.
Chapter 3, the Meningococcal Group B Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Group B Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Meningococcal Group B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Group B Vaccine.
Chapter 14 and 15, to describe Meningococcal Group B Vaccine sales channel, distributors, customers, research findings and conclusion.
Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Meningococcal Group B Vaccine industry chain, the market status of Public (Bexsero, Trumenba), Private (Bexsero, Trumenba), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Meningococcal Group B Vaccine.
Regionally, the report analyzes the Meningococcal Group B Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Meningococcal Group B Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Meningococcal Group B Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Meningococcal Group B Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Bexsero, Trumenba).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Meningococcal Group B Vaccine market.
Regional Analysis: The report involves examining the Meningococcal Group B Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Meningococcal Group B Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Meningococcal Group B Vaccine:
Company Analysis: Report covers individual Meningococcal Group B Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Meningococcal Group B Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Meningococcal Group B Vaccine. It assesses the current state, advancements, and potential future developments in Meningococcal Group B Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Meningococcal Group B Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Meningococcal Group B Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Bexsero
- Trumenba
- Other
- Public
- Private
- GSK
- Pfizer
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Meningococcal Group B Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Group B Vaccine, with price, sales, revenue and global market share of Meningococcal Group B Vaccine from 2019 to 2024.
Chapter 3, the Meningococcal Group B Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Group B Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Meningococcal Group B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Group B Vaccine.
Chapter 14 and 15, to describe Meningococcal Group B Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Meningococcal Group B Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meningococcal Group B Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Bexsero
1.3.3 Trumenba
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Meningococcal Group B Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public
1.4.3 Private
1.5 Global Meningococcal Group B Vaccine Market Size & Forecast
1.5.1 Global Meningococcal Group B Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Meningococcal Group B Vaccine Sales Quantity (2019-2030)
1.5.3 Global Meningococcal Group B Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Meningococcal Group B Vaccine Product and Services
2.1.4 GSK Meningococcal Group B Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Meningococcal Group B Vaccine Product and Services
2.2.4 Pfizer Meningococcal Group B Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MENINGOCOCCAL GROUP B VACCINE BY MANUFACTURER
3.1 Global Meningococcal Group B Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Meningococcal Group B Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Meningococcal Group B Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Meningococcal Group B Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Meningococcal Group B Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Meningococcal Group B Vaccine Manufacturer Market Share in 2023
3.5 Meningococcal Group B Vaccine Market: Overall Company Footprint Analysis
3.5.1 Meningococcal Group B Vaccine Market: Region Footprint
3.5.2 Meningococcal Group B Vaccine Market: Company Product Type Footprint
3.5.3 Meningococcal Group B Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Meningococcal Group B Vaccine Market Size by Region
4.1.1 Global Meningococcal Group B Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Meningococcal Group B Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Meningococcal Group B Vaccine Average Price by Region (2019-2030)
4.2 North America Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.3 Europe Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.5 South America Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Meningococcal Group B Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Meningococcal Group B Vaccine Consumption Value by Type (2019-2030)
5.3 Global Meningococcal Group B Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Meningococcal Group B Vaccine Consumption Value by Application (2019-2030)
6.3 Global Meningococcal Group B Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Meningococcal Group B Vaccine Market Size by Country
7.3.1 North America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Meningococcal Group B Vaccine Market Size by Country
8.3.1 Europe Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Meningococcal Group B Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Meningococcal Group B Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Meningococcal Group B Vaccine Market Size by Country
10.3.1 South America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Meningococcal Group B Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Meningococcal Group B Vaccine Market Drivers
12.2 Meningococcal Group B Vaccine Market Restraints
12.3 Meningococcal Group B Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Meningococcal Group B Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meningococcal Group B Vaccine
13.3 Meningococcal Group B Vaccine Production Process
13.4 Meningococcal Group B Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meningococcal Group B Vaccine Typical Distributors
14.3 Meningococcal Group B Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Meningococcal Group B Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meningococcal Group B Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Bexsero
1.3.3 Trumenba
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Meningococcal Group B Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public
1.4.3 Private
1.5 Global Meningococcal Group B Vaccine Market Size & Forecast
1.5.1 Global Meningococcal Group B Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Meningococcal Group B Vaccine Sales Quantity (2019-2030)
1.5.3 Global Meningococcal Group B Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Meningococcal Group B Vaccine Product and Services
2.1.4 GSK Meningococcal Group B Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Meningococcal Group B Vaccine Product and Services
2.2.4 Pfizer Meningococcal Group B Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MENINGOCOCCAL GROUP B VACCINE BY MANUFACTURER
3.1 Global Meningococcal Group B Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Meningococcal Group B Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Meningococcal Group B Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Meningococcal Group B Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Meningococcal Group B Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Meningococcal Group B Vaccine Manufacturer Market Share in 2023
3.5 Meningococcal Group B Vaccine Market: Overall Company Footprint Analysis
3.5.1 Meningococcal Group B Vaccine Market: Region Footprint
3.5.2 Meningococcal Group B Vaccine Market: Company Product Type Footprint
3.5.3 Meningococcal Group B Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Meningococcal Group B Vaccine Market Size by Region
4.1.1 Global Meningococcal Group B Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Meningococcal Group B Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Meningococcal Group B Vaccine Average Price by Region (2019-2030)
4.2 North America Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.3 Europe Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.5 South America Meningococcal Group B Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Meningococcal Group B Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Meningococcal Group B Vaccine Consumption Value by Type (2019-2030)
5.3 Global Meningococcal Group B Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Meningococcal Group B Vaccine Consumption Value by Application (2019-2030)
6.3 Global Meningococcal Group B Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Meningococcal Group B Vaccine Market Size by Country
7.3.1 North America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Meningococcal Group B Vaccine Market Size by Country
8.3.1 Europe Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Meningococcal Group B Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Meningococcal Group B Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Meningococcal Group B Vaccine Market Size by Country
10.3.1 South America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Meningococcal Group B Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Meningococcal Group B Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Meningococcal Group B Vaccine Market Drivers
12.2 Meningococcal Group B Vaccine Market Restraints
12.3 Meningococcal Group B Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Meningococcal Group B Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meningococcal Group B Vaccine
13.3 Meningococcal Group B Vaccine Production Process
13.4 Meningococcal Group B Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meningococcal Group B Vaccine Typical Distributors
14.3 Meningococcal Group B Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Meningococcal Group B Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Meningococcal Group B Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Meningococcal Group B Vaccine Product and Services
Table 6. GSK Meningococcal Group B Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Meningococcal Group B Vaccine Product and Services
Table 11. Pfizer Meningococcal Group B Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Global Meningococcal Group B Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 14. Global Meningococcal Group B Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 15. Global Meningococcal Group B Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 16. Market Position of Manufacturers in Meningococcal Group B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 17. Head Office and Meningococcal Group B Vaccine Production Site of Key Manufacturer
Table 18. Meningococcal Group B Vaccine Market: Company Product Type Footprint
Table 19. Meningococcal Group B Vaccine Market: Company Product Application Footprint
Table 20. Meningococcal Group B Vaccine New Market Entrants and Barriers to Market Entry
Table 21. Meningococcal Group B Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Meningococcal Group B Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 23. Global Meningococcal Group B Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 24. Global Meningococcal Group B Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 25. Global Meningococcal Group B Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 26. Global Meningococcal Group B Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 27. Global Meningococcal Group B Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 28. Global Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 29. Global Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 30. Global Meningococcal Group B Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 31. Global Meningococcal Group B Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 32. Global Meningococcal Group B Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 33. Global Meningococcal Group B Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 34. Global Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 35. Global Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 36. Global Meningococcal Group B Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 37. Global Meningococcal Group B Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 38. Global Meningococcal Group B Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Meningococcal Group B Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 40. North America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 41. North America Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 42. North America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 43. North America Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 44. North America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 45. North America Meningococcal Group B Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 46. North America Meningococcal Group B Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 47. North America Meningococcal Group B Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 48. Europe Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Europe Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Europe Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 51. Europe Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 52. Europe Meningococcal Group B Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 53. Europe Meningococcal Group B Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 54. Europe Meningococcal Group B Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Meningococcal Group B Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 57. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 58. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 59. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 60. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 61. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 62. Asia-Pacific Meningococcal Group B Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 63. Asia-Pacific Meningococcal Group B Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 64. South America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 65. South America Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 66. South America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 67. South America Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 68. South America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 69. South America Meningococcal Group B Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 70. South America Meningococcal Group B Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 71. South America Meningococcal Group B Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 73. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 74. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 77. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 78. Middle East & Africa Meningococcal Group B Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Middle East & Africa Meningococcal Group B Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 80. Meningococcal Group B Vaccine Raw Material
Table 81. Key Manufacturers of Meningococcal Group B Vaccine Raw Materials
Table 82. Meningococcal Group B Vaccine Typical Distributors
Table 83. Meningococcal Group B Vaccine Typical Customers
Table 1. Global Meningococcal Group B Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Meningococcal Group B Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Meningococcal Group B Vaccine Product and Services
Table 6. GSK Meningococcal Group B Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Meningococcal Group B Vaccine Product and Services
Table 11. Pfizer Meningococcal Group B Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Global Meningococcal Group B Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 14. Global Meningococcal Group B Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 15. Global Meningococcal Group B Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 16. Market Position of Manufacturers in Meningococcal Group B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 17. Head Office and Meningococcal Group B Vaccine Production Site of Key Manufacturer
Table 18. Meningococcal Group B Vaccine Market: Company Product Type Footprint
Table 19. Meningococcal Group B Vaccine Market: Company Product Application Footprint
Table 20. Meningococcal Group B Vaccine New Market Entrants and Barriers to Market Entry
Table 21. Meningococcal Group B Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Meningococcal Group B Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 23. Global Meningococcal Group B Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 24. Global Meningococcal Group B Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 25. Global Meningococcal Group B Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 26. Global Meningococcal Group B Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 27. Global Meningococcal Group B Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 28. Global Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 29. Global Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 30. Global Meningococcal Group B Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 31. Global Meningococcal Group B Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 32. Global Meningococcal Group B Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 33. Global Meningococcal Group B Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 34. Global Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 35. Global Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 36. Global Meningococcal Group B Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 37. Global Meningococcal Group B Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 38. Global Meningococcal Group B Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Meningococcal Group B Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 40. North America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 41. North America Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 42. North America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 43. North America Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 44. North America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 45. North America Meningococcal Group B Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 46. North America Meningococcal Group B Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 47. North America Meningococcal Group B Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 48. Europe Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Europe Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Europe Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 51. Europe Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 52. Europe Meningococcal Group B Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 53. Europe Meningococcal Group B Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 54. Europe Meningococcal Group B Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Meningococcal Group B Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 57. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 58. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 59. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 60. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 61. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 62. Asia-Pacific Meningococcal Group B Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 63. Asia-Pacific Meningococcal Group B Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 64. South America Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 65. South America Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 66. South America Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 67. South America Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 68. South America Meningococcal Group B Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 69. South America Meningococcal Group B Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 70. South America Meningococcal Group B Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 71. South America Meningococcal Group B Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 73. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 74. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 77. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 78. Middle East & Africa Meningococcal Group B Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Middle East & Africa Meningococcal Group B Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 80. Meningococcal Group B Vaccine Raw Material
Table 81. Key Manufacturers of Meningococcal Group B Vaccine Raw Materials
Table 82. Meningococcal Group B Vaccine Typical Distributors
Table 83. Meningococcal Group B Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Meningococcal Group B Vaccine Picture
Figure 2. Global Meningococcal Group B Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Meningococcal Group B Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Bexsero Examples
Figure 5. Trumenba Examples
Figure 6. Other Examples
Figure 7. Global Meningococcal Group B Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Meningococcal Group B Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Public Examples
Figure 10. Private Examples
Figure 11. Global Meningococcal Group B Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Meningococcal Group B Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Meningococcal Group B Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Meningococcal Group B Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Meningococcal Group B Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Meningococcal Group B Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Meningococcal Group B Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Meningococcal Group B Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Meningococcal Group B Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Meningococcal Group B Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Meningococcal Group B Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Meningococcal Group B Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Meningococcal Group B Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Meningococcal Group B Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Meningococcal Group B Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Meningococcal Group B Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Meningococcal Group B Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Meningococcal Group B Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Meningococcal Group B Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Meningococcal Group B Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Meningococcal Group B Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Meningococcal Group B Vaccine Market Drivers
Figure 74. Meningococcal Group B Vaccine Market Restraints
Figure 75. Meningococcal Group B Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Meningococcal Group B Vaccine in 2023
Figure 78. Manufacturing Process Analysis of Meningococcal Group B Vaccine
Figure 79. Meningococcal Group B Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Meningococcal Group B Vaccine Picture
Figure 2. Global Meningococcal Group B Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Meningococcal Group B Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Bexsero Examples
Figure 5. Trumenba Examples
Figure 6. Other Examples
Figure 7. Global Meningococcal Group B Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Meningococcal Group B Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Public Examples
Figure 10. Private Examples
Figure 11. Global Meningococcal Group B Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Meningococcal Group B Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Meningococcal Group B Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Meningococcal Group B Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Meningococcal Group B Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Meningococcal Group B Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Meningococcal Group B Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Meningococcal Group B Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Meningococcal Group B Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Meningococcal Group B Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Meningococcal Group B Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Meningococcal Group B Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Meningococcal Group B Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Meningococcal Group B Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Meningococcal Group B Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Meningococcal Group B Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Meningococcal Group B Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Meningococcal Group B Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Meningococcal Group B Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Meningococcal Group B Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Meningococcal Group B Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Meningococcal Group B Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Meningococcal Group B Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Meningococcal Group B Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Meningococcal Group B Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Meningococcal Group B Vaccine Market Drivers
Figure 74. Meningococcal Group B Vaccine Market Restraints
Figure 75. Meningococcal Group B Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Meningococcal Group B Vaccine in 2023
Figure 78. Manufacturing Process Analysis of Meningococcal Group B Vaccine
Figure 79. Meningococcal Group B Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
